Dendritic cells

In one sentence

Dendritic cells are immune cells that collect and present antigen and can help start or shape T-cell responses through accompanying signals.

The intuition

Finding information and giving a useful briefing are different tasks. A dendritic cell can do both: collect material and present selected fragments in a response-shaping context. It is not simply a courier carrying an intact tumor label. The cell processes material, changes with its environment and can support tolerance as well as activation.

How it works

Antigen is material recognized by an immune receptor. Dendritic cells, often abbreviated DCs, acquire material from their surroundings or make antigen internally. They process proteins and display fragments using human leukocyte antigen (HLA). A suitable T-cell receptor (TCR) recognizes a displayed peptide–HLA pair.

For class I presentation, internally made proteins can supply peptides. Cross-presentation routes acquired external material onto class I. Class II presentation is another route, commonly involving acquired proteins and CD4 T cells. These categories describe processing and recognition; they do not establish successful priming by themselves.

DCs are a family with distinct subsets and overlapping functions. Conventional type 1 dendritic cells (cDC1) are particularly important in cross-presentation. Hildner and colleagues used Batf3-deficient mice to show how losing a key DC population impaired cross-presentation and antitumor responses in their models. That is a specific dependency, not proof that every DC performs the same job or that a human biopsy count predicts benefit.

Some DCs migrate from tissue to draining lymph nodes. Others already reside in lymphoid tissue and acquire incoming material. Sixt and colleagues demonstrated soluble-antigen access to resident DCs through lymph-node conduits. Both routes can connect tissue information with responding cells.

Presentation comes with a signal context. Costimulation, inhibitory interactions and cytokines shape what a responding T cell does. Priming means initiating an antigen-driven response in a naive T cell. Mature-looking markers, antigen uptake and functional priming are different observations.

Dendritic cells connect antigen information with response context. Every arrow has requirements.

Why it matters in cancer

Tumor material may be present without effective immune teaching. DC recruitment, antigen access and supportive state can each become a bottleneck. Böttcher and colleagues showed natural killer-cell signals recruiting cDC1 in mouse tumors, with related human associations. This illustrates cooperation between cell types; it does not make one cell count a complete immune map.

A vaccine may reach a DC that then makes the encoded protein. Its class I display need not be cross-presentation. Separately, the cancer cell must still display a recognizable target for a conventional antigen-specific CD8 T cell to attack it. Successful DC presentation does not repair a cancer cell's missing display system.

Common confusions

A dendritic cell is not the same as a neuron with branching dendrites.
Antigen uptake is not proof of presentation or priming.
Cross-presentation does not describe all class I presentation by DCs.
A low count in one tumor biopsy does not prove no priming occurred in another compartment.

How it is measured

Flow cytometry and tissue staining use combinations of markers to identify populations. Spatial methods add location; RNA methods add programs. Functional tests ask whether identified cells present a defined target and stimulate a suitable responder under controlled conditions. Preserve subset definitions, specimen site and timing when comparing results.

Try it

A fictional DC displays a tumor peptide and activates a matching naive T cell. The cancer cells have lost the relevant HLA allele. Has the experiment established that the activated cells can recognize those cancer cells?

Answer: No. The DC supplied a priming opportunity. Natural cancer-cell display is a separate requirement and needs its own test.

Sources and scope

Source check: October 9, 2026. Presentation, trafficking and cooperation; the exercise is fictional. Expert and learner review remain pending.

Hildner et al., 2008 — DC-subset dependence in mouse cross-presentation and tumor-rejection models.
Sixt et al., 2005 — soluble material reaching resident DCs in mouse lymph nodes.
Böttcher et al., 2018 — natural killer-cell/DC cooperation in tumor models and human associations.
NCBI Bookshelf: T cells and antigen-presenting cells — the broader presentation and priming framework.